Rochem Methotrexate Rochem Methotrexate

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Methotrexate on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 100MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/VIAL
  • INJECTABLE;INJECTION - EQ 1GM BASE/40ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5GM BASE/100ML (EQ 25MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 2.5MG BASE/ML
  • INJECTABLE;INJECTION - EQ 20MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 20MG BASE/2ML (EQ 10MG BASE/ML)
  • INJECTABLE;INJECTION - EQ 25MG BASE/ML
  • INJECTABLE;INJECTION - EQ 500MG BASE/20ML (EQ 25MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INJECTION - EQ 50MG BASE/VIAL
  • INJECTABLE;INJECTION - EQ 50MG BASE/2ML (EQ 25MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - 10MG/0.4ML (10MG/0.4ML)
  • SOLUTION;SUBCUTANEOUS - 12.5MG/0.5ML (12.5MG/0.5ML)
  • SOLUTION;SUBCUTANEOUS - 15MG/0.6ML (15MG/0.6ML)
  • SOLUTION;SUBCUTANEOUS - 17.5MG/0.7ML (17.5MG/0.7ML)
  • SOLUTION;SUBCUTANEOUS - 20MG/0.8ML (20MG/0.8ML)
  • SOLUTION;SUBCUTANEOUS - 22.5MG/ML (22.5MG/ML)
  • SOLUTION;SUBCUTANEOUS - 25MG/1ML (25MG/1ML)
  • SOLUTION;SUBCUTANEOUS - 7.5MG/0.3ML (7.5MG/0.3ML)
  • TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9259427
Y
2033-01-02
208400
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10610485
Y
2033-01-02
208400
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8664231
2029-06-01
U-1442
205776
SUBCUTANEOUS INJECTION OF METHOTREXATE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
8664231
2029-06-01
U-1442
205776
SUBCUTANEOUS INJECTION OF METHOTREXATE
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
11129833
Y
2035-10-28
212479
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8480631
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
10709844
Y
2029-03-10
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11684723
Y
2029-03-10
204824
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9867949
Y
2029-03-10
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8579865
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9867949
Y
2029-03-10
204824
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9533102
Y
2026-01-24
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8480631
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8562564
Y
2026-01-24
204824
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8562564
Y
2026-01-24
204824
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8579865
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8021335
Y
2026-10-04
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11684723
Y
2029-03-10
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8814834
Y
2031-05-27
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11684723
Y
2029-03-10
204824
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8480631
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11684723
Y
2029-03-10
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9867949
Y
2029-03-10
204824
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9629959
Y
2026-01-24
204824
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8562564
Y
2026-01-24
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9629959
Y
2026-01-24
204824
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9629959
Y
2026-01-24
204824
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
10709844
Y
2029-03-10
204824
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8945063
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11684723
Y
2029-03-10
204824
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8945063
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11446441
Y
2026-01-24
204824
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8579865
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8814834
Y
2031-05-27
204824
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8579865
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
10709844
Y
2029-03-10
204824
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
10709844
Y
2029-03-10
204824
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8814834
Y
2031-05-27
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9629959
Y
2026-01-24
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
8579865
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9533102
Y
2026-01-24
204824
5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
9421333
Y
2030-03-19
U-1442
204824
SUBCUTANEOUS INJECTION OF METHOTREXATE
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11497753
Y
2030-03-19
204824
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11497753
Y
2030-03-19
204824
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

OTTER PHARMS

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
11446441
Y
2026-01-24
204824
7
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY